Ema, a Universal AI Employee, is the leading enterprise partner for building and deploying Agentic AI across all roles and industries.

22 мар. 2024 г. · An artificial intelligence (AI) workplan for the European medicines regulatory network is available to guide the use of AIin medicines ...

The European Medicines Agency's scientific guidelines on artificial intelligence help medicine developers prepare marketing authorisation applications for ...

18 дек. 2023 г. · The workplan will help the European medicines regulatory network (EMRN) to embrace the opportunities of AI for personal productivity.

3 окт. 2024 г. · The Paper reflects the views of the EMA on the use of AI from drug discovery and non-clinical development, to clinical trials, manufacturing and ...

European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) are hosting a workshop on AI. The workshop will provide updates on:

24 окт. 2024 г. · KPMG announced a minority equity investment in Ema, an agentic AI startup building universal AI employees.

31 окт. 2024 г. · The document outlines the potential for AI to transform the development, authorisation and post- authorisation stages, while also addressing ...

31 июл. 2024 г. · With over 200 pre-built connectors, Ema's AI Employees seamlessly integrate with internal data sources, create knowledge graphs, learn from ...

The European Medicines Agency (EMA) has adopted a reflection paper (RP) on using artificial intelligence (AI) in drug development after considering feedback ...